tissue plasminogen activator
Showing 1 - 25 of >10,000
Acute Respiratory Failure, Hypercoagulability, Fibrinolysis Shutdown Trial in Liverpool (Alteplase)
Recruiting
- Acute Respiratory Failure
- +2 more
-
Liverpool, New South Wales, AustraliaIntensive Care Unit, Liverpool Hospital, South Western Sydney Lo
Sep 15, 2022
Pleural Infection Trial in Hong Kong (Tissue Plasminogen Activator)
Not yet recruiting
- Pleural Infection
- Tissue Plasminogen Activator
-
Hong Kong, Hong Kong
- +1 more
Mar 10, 2023
Ocular Trauma Trial in Hangzhou (Tissue Plasminogen Activator)
Recruiting
- Ocular Trauma
- Tissue Plasminogen Activator
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 20, 2023
Hematoma, Subdural, Fibrinolytic; Hemorrhage Trial in Hamilton (Tissue Plasminogen Activator, Placebo)
Not yet recruiting
- Hematoma, Subdural
- Fibrinolytic; Hemorrhage
- Tissue Plasminogen Activator
- Placebo
-
Hamilton, Ontario, CanadaHamilton General Hospital
Aug 4, 2022
Menstrual Bleeding, Heavy Trial in Portland (Sample Collection and Endometrial Biopsy)
Not yet recruiting
- Menstrual Bleeding, Heavy
- Sample Collection and Endometrial Biopsy
-
Portland, OregonOHSU
May 8, 2023
Acute Stroke Trial in Izmir (theory training, theory and simulation training)
Completed
- Acute Stroke
- theory training
- theory and simulation training
-
İzmir, TurkeyOzge Soydaner
Jul 15, 2022
Recombinant Tissue Plasminogen Activator Treated Chinese Acute
Completed
- Stroke
-
Shanghai, ChinaBoehringer Ingelheim (China) Investment Co., ltd.
Dec 22, 2022
Acute Ischemic Stroke Trial (IV tPA (Activase))
Not yet recruiting
- Acute Ischemic Stroke
- IV tPA (Activase)
- (no location specified)
Feb 24, 2022
Alteplase in Elderly Acute Ischemic Stroke Patients During
Active, not recruiting
- Stroke
-
Shanghai, ChinaBoehringer Ingelheim (China) Investment Co., ltd.
Jan 9, 2023
Pleural Infection Trial (Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg, Saline irrigation with 250 mls normal
Not yet recruiting
- Pleural Infection
- Intrapleural fibrinolytic with alteplase 5mg and pulmozyme 5 mg
- Saline irrigation with 250 mls normal saline (over 1 hour)
- (no location specified)
Jun 19, 2023
Stroke, Acute Ischemic Trial (Tissue Plasminogen Activator (Alteplase))
Not yet recruiting
- Stroke, Acute Ischemic
- Tissue Plasminogen Activator (Alteplase)
- (no location specified)
Aug 16, 2022
Ischemic Stroke, Acute Trial (Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA), Best Medical
Not yet recruiting
- Ischemic Stroke, Acute
- Recombinant Human tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA)
- Best Medical Management
- (no location specified)
Nov 24, 2022
Tissue Plasminogen Activator Trial in Columbia (early tPA and DNase)
Withdrawn
- Tissue Plasminogen Activator
- early tPA and DNase
-
Columbia, South CarolinaPalmetto Health Richland
Jan 31, 2022
Acute Ischemic Stroke, Arterial Thrombosis, Posterior Circulation Brain Infarction Trial in Beijing (intra-arterial alteplase)
Not yet recruiting
- Acute Ischemic Stroke
- +2 more
- intra-arterial alteplase
-
Beijing, ChinaXuanwu Hospital, Capital Medical University.
Jun 8, 2023
Reduced Dose Thrombolytic in Intermediate/High Risk Pulmonary
Recruiting
- Pulmonary Embolism
- Tissue Plasminogen Activator, Alteplase
- Low-molecular weight heparin
-
İzmir, Bornova/İzmir, TurkeyEge University
Aug 22, 2022
Periodontal Diseases, Periodontal Attachment Loss, Periodontal Disease, AVDC Stage 3 Trial in Istanbul (low level laser therapy,
Completed
- Periodontal Diseases
- +4 more
- low level laser therapy
- non-surgical periodontal treatment
-
Istanbul, TurkeyBeykent University
Jan 31, 2022
COVID Trial in London (nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1, nebulised recombinant
Recruiting
- COVID
- nebulised recombinant tissue-Plasminogen Activator (rt-PA) - Cohort 1
- +2 more
-
London, United Kingdom
- +1 more
Apr 1, 2021
Stroke, Ischemic Trial in ShenYang (Butyphthalide combined with rtPA, rtPA)
Completed
- Stroke, Ischemic
- Butyphthalide combined with rtPA
- rtPA
-
ShenYang, ChinaGeneral Hospital of ShenYang Military Region
Jun 1, 2021
Acute Respiratory Distress Syndrome Trial (Tissue plasminogen activator, Ringer solution)
Withdrawn
- Acute Respiratory Distress Syndrome
- Tissue plasminogen activator
- Ringer solution
- (no location specified)
Mar 10, 2021
Ischemic Stroke Trial (3K3A-APC, Placebo)
Not yet recruiting
- Ischemic Stroke
- 3K3A-APC
- Placebo
- (no location specified)
Jul 29, 2022
Stroke, Brain Ischemia Trial in United States (device, drug, procedure)
Recruiting
- Stroke
- Brain Ischemia
- ThermoSuit Cooling Induction
- +5 more
-
New Orleans, Louisiana
- +3 more
Jul 12, 2022
Stroke, Ischemic Trial in Shenyang (TNK-Tissue Plasminogen Activator)
Recruiting
- Stroke, Ischemic
- TNK-Tissue Plasminogen Activator
-
Shenyang, ChinaDepartment of Neurology, General Hospital of Northern Theater Co
Feb 10, 2022
Eye Diseases, Macular Degeneration, Wet, Sub-Macular Hemorrhage Trial in United Kingdom (Pars plana vitrectomy, Intravitreal 2
Recruiting
- Eye Diseases
- +2 more
- Pars plana vitrectomy
- +3 more
-
Chelmsford, Essex, United Kingdom
- +13 more
Aug 2, 2022
Stroke, Acute, Stroke Ischemic Trial in Melbourne (Tenecteplase, Intravenous tissue plasminogen activator (tPA))
Completed
- Stroke, Acute, Stroke Ischemic
- Tenecteplase
- Intravenous tissue plasminogen activator (tPA)
-
Melbourne, Victoria, Australia
- +4 more
Dec 6, 2021